Healthcare - Biotechnology - NASDAQ - CN
$ 2.16
-6.9 %
$ 95.6 M
Market Cap
-2.96
P/E
INCOME STATEMENT
18.1 M
REVENUE
-23.7 M
OPERATING INCOME
-18.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Adagene Inc.
| Revenue | 18.1 M |
| Cost Of Revenue | 0 |
| Gross Profit | 18.1 M |
| Operating Expenses | 41.8 M |
| Operating Income | -23.7 M |
| Other Expenses | -4.77 M |
| Net Income | -18.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 18.1 | 9.3 | 10.2 | 0.5 | 0.5 | 1.5 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 18.1 | 9.3 | 10.2 | 0.5 | 0.5 | 1.5 |
| OPERATING INCOME | ||||||
| Operating Expenses | 41.8 | 93.2 | 82.5 | 19.6 | 19.6 | 18.8 |
| Selling, General and Administrative Expenses | 8.7 | 11.9 | 14.4 | 3.4 | 3.4 | 2.8 |
| Research and Development Expenses | 36.6 | 81.3 | 68.1 | 16.2 | 16.2 | 16.1 |
| Operating Income | (23.7) | (83.9) | (72.4) | (19.2) | (19.2) | (17.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 1.1 | 0.7 | 0.4 | 0.1 | 0.1 | 91.1 K |
| Total Other Income | 6.5 | 4.4 | 0.9 | 0.8 | 2.7 | 2.1 |
| Pre-Tax Income | (17.3) | (79.5) | (71.5) | (16.4) | (16.4) | (15.3) |
| NET INCOME | ||||||
| Tax Provision | 1.7 | 0.5 | 1.7 | 3.16 K | 0.9 | (0.5) |
| Net Income | (18.9) | (80.0) | (73.2) | (16.4) | (17.3) | (14.7) |
| EPS | 0.44 | 1.85 | 1.83 | 0.47 | 0.39 | 0.43 |